Consolidated Balance Sheets Statement - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 17,219	$ 22,494
Accounts receivable, net of allowance for doubtful accounts of $3,146 and $4,136 at 2016 and 2015, respectively	108,520	145,689
Inventories	37,339	40,906
Prepaid expenses	8,971	12,053
Income taxes receivable	6,374	7,209
Other current assets	6,931	10,196
TOTAL CURRENT ASSETS	185,354	238,547
PROPERTY, PLANT AND EQUIPMENT, net	131,210	143,211
INTANGIBLES, net	10,019	10,041
GOODWILL	179,044	178,159
DEFERRED TAX ASSETS, net	9,793	11,693
OTHER ASSETS	46,718	43,607
TOTAL ASSETS	562,138	625,258
CURRENT LIABILITIES:
Accounts payable	32,201	33,474
Accrued payroll and related costs	23,541	36,475
Taxes other than payroll and income	6,816	9,495
Unearned revenue	12,990	14,101
Income taxes payable	5,596	1,733
Other current liabilities	12,398	25,480
TOTAL CURRENT LIABILITIES	93,542	120,758
LONG-TERM DEBT, net	206,363	430,987
DEFERRED COMPENSATION	45,977	43,478
DEFERRED TAX LIABILITIES, net	5,859	4,881
OTHER LONG-TERM LIABILITIES	47,600	48,853
COMMITMENTS AND CONTINGENCIES (Note 6)
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,796,252 issued and 44,100,116 outstanding at 2016 and 44,350,002 issued and 42,375,905 outstanding at 2015	1,148	1,142
Additional paid-in capital	62,479	0
Retained earnings	196,760	219,207
Accumulated other comprehensive income (loss)	(11,253)	(10,538)
Treasury shares (at cost), 696,136 at 2016 and 1,974,097 at 2015	(91,545)	(238,875)
Total Core Laboratories N.V. shareholders' equity (deficit)	157,589	(29,064)
Non-controlling interest	5,208	5,365
TOTAL EQUITY (DEFICIT)	162,797	(23,699)
TOTAL LIABILITIES AND EQUITY (DEFICIT)	$ 562,138	$ 625,258